A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
Clinical trial NCT00299546 · COMPLETED
Trial details
- NCT number
- NCT00299546
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-08-01
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.